609-38-1,MFCD00236147
Catalog No.:AA003H9N

609-38-1 | 2-Furamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%(GC)
in stock  
$32.00   $23.00
- +
5g
98%
in stock  
$65.00   $45.00
- +
25g
96%
in stock  
$211.00   $148.00
- +
100g
96%
in stock  
$643.00 $450.00
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA003H9N
Chemical Name:
2-Furamide
CAS Number:
609-38-1
Molecular Formula:
C5H5NO2
Molecular Weight:
111.0987
MDL Number:
MFCD00236147
SMILES:
NC(=O)c1ccco1
NSC Number:
9351
Properties
Properties
 
BP:
274.6°C at 760 mmHg  
Form:
Solid  
MP:
138-140°C  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
103  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.1  

Literature

Title: Asymmetric synthesis and cytotoxicity of (-)-saframycin A analogues.

Journal: European journal of medicinal chemistry 20120301

Title: Cyclization vs. cyclization/dimerization in o-amidostilbene radical cation cascade reactions: the amide question.

Journal: Molecules (Basel, Switzerland) 20110825

Title: An IMDAF cycloaddition approach toward the synthesis of the lycopodium alkaloid (±)-fawcettidine.

Journal: The Journal of organic chemistry 20110415

Title: Simultaneous determination of diloxanide furoate and metronidazole in presence of diloxanide furoate degradation products.

Journal: Journal of AOAC International 20110101

Title: Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds.

Journal: Bioorganic & medicinal chemistry 20100915

Title: Cecal ameboma.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20100101

Title: Validation and application of chemometrics-assisted spectrophotometry and liquid chromatography for simultaneous determination of two ternary mixtures containing drotaverine hydrochloride.

Journal: Journal of AOAC International 20100101

Title: Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan.

Journal: Chemotherapy 20100101

Title: Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate.

Journal: International journal of pharmaceutics 20080709

Title: Stability indicating reversed-phase liquid chromatographic determination of metronidazole benzoate and diloxanide furoate as bulk drug and in suspension dosage form.

Journal: Journal of pharmaceutical and biomedical analysis 20050915

Title: Stability studies on diloxanide furoate: effect of pH, temperature, gastric and intestinal fluids.

Journal: Farmaco (Societa chimica italiana : 1989) 20040401

Title: Enzymatic hydrolysis of diloxanide furoate in the presence of beta-cyclodextrin and its methylated derivatives.

Journal: International journal of pharmaceutics 20031128

Title: Intramolecular cyclization reactions of 5-halo- and 5-nitro-substituted furans.

Journal: Organic letters 20030904

Title: Treatment of asymptomatic intestinal Entamoeba histolytica infection.

Journal: The New England journal of medicine 20021024

Title: Synthesis and microbiological activity of some N-(2-hydroxy-4-substitutedphenyl)benzamides, phenylacetamides and furamides as the possible metabolites of antimicrobial active benzoxazoles.

Journal: Farmaco (Societa chimica italiana : 1989) 20020601

Title: Stability indicating methods for the determination of diloxanide furoate.

Journal: Journal of pharmaceutical and biomedical analysis 20020415

Title: Spectrophotometric determination of diloxanide furoate in its dosage forms.

Journal: Farmaco (Societa chimica italiana : 1989) 20010901

Title: Molecular modelling of ligand-DNA minor groove binding: role of ligand-water interactions.

Journal: Journal of biomolecular structure & dynamics 20010801

Title: Inhibition of Cryptosporidium infection in mice treated with a cyclodextrin inclusion complex with diloxanide furoate.

Journal: Parasitology research 20010601

Title: Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 19920901

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:609-38-1 Molecular Formula|609-38-1 MDL|609-38-1 SMILES|609-38-1 2-Furamide
Catalog No.: AA003H9N
609-38-1,MFCD00236147
609-38-1 | 2-Furamide
Pack Size: 1g
Purity: 98%(GC)
in stock
$32.00 $23.00
Pack Size: 5g
Purity: 98%
in stock
$65.00 $45.00
Pack Size: 25g
Purity: 96%
in stock
$211.00 $148.00
Pack Size: 100g
Purity: 96%
in stock
$643.00 $450.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA003H9N
Chemical Name: 2-Furamide
CAS Number: 609-38-1
Molecular Formula: C5H5NO2
Molecular Weight: 111.0987
MDL Number: MFCD00236147
SMILES: NC(=O)c1ccco1
NSC Number: 9351
Properties
BP: 274.6°C at 760 mmHg  
Form: Solid  
MP: 138-140°C  
Storage: Inert atmosphere;2-8℃;  
Complexity: 103  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 8  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.1  
Literature fold

Title: Asymmetric synthesis and cytotoxicity of (-)-saframycin A analogues.

Journal: European journal of medicinal chemistry20120301

Title: Cyclization vs. cyclization/dimerization in o-amidostilbene radical cation cascade reactions: the amide question.

Journal: Molecules (Basel, Switzerland)20110825

Title: An IMDAF cycloaddition approach toward the synthesis of the lycopodium alkaloid (±)-fawcettidine.

Journal: The Journal of organic chemistry20110415

Title: Simultaneous determination of diloxanide furoate and metronidazole in presence of diloxanide furoate degradation products.

Journal: Journal of AOAC International20110101

Title: Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds.

Journal: Bioorganic & medicinal chemistry20100915

Title: Cecal ameboma.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association20100101

Title: Validation and application of chemometrics-assisted spectrophotometry and liquid chromatography for simultaneous determination of two ternary mixtures containing drotaverine hydrochloride.

Journal: Journal of AOAC International20100101

Title: Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan.

Journal: Chemotherapy20100101

Title: Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate.

Journal: International journal of pharmaceutics20080709

Title: Stability indicating reversed-phase liquid chromatographic determination of metronidazole benzoate and diloxanide furoate as bulk drug and in suspension dosage form.

Journal: Journal of pharmaceutical and biomedical analysis20050915

Title: Stability studies on diloxanide furoate: effect of pH, temperature, gastric and intestinal fluids.

Journal: Farmaco (Societa chimica italiana : 1989)20040401

Title: Enzymatic hydrolysis of diloxanide furoate in the presence of beta-cyclodextrin and its methylated derivatives.

Journal: International journal of pharmaceutics20031128

Title: Intramolecular cyclization reactions of 5-halo- and 5-nitro-substituted furans.

Journal: Organic letters20030904

Title: Treatment of asymptomatic intestinal Entamoeba histolytica infection.

Journal: The New England journal of medicine20021024

Title: Synthesis and microbiological activity of some N-(2-hydroxy-4-substitutedphenyl)benzamides, phenylacetamides and furamides as the possible metabolites of antimicrobial active benzoxazoles.

Journal: Farmaco (Societa chimica italiana : 1989)20020601

Title: Stability indicating methods for the determination of diloxanide furoate.

Journal: Journal of pharmaceutical and biomedical analysis20020415

Title: Spectrophotometric determination of diloxanide furoate in its dosage forms.

Journal: Farmaco (Societa chimica italiana : 1989)20010901

Title: Molecular modelling of ligand-DNA minor groove binding: role of ligand-water interactions.

Journal: Journal of biomolecular structure & dynamics20010801

Title: Inhibition of Cryptosporidium infection in mice treated with a cyclodextrin inclusion complex with diloxanide furoate.

Journal: Parasitology research20010601

Title: Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America19920901

Building Blocks More >
6270-63-9
6270-63-9
2-Hydroxypyrazine
AA003HD9 | MFCD00233966
88569-83-9
88569-83-9
2-Methoxy-6-methylaminopyridine
AA003HGR | MFCD00191557
67715-80-4
67715-80-4
2-Methyl-4-propyl-1,3-oxathiane
AA003HKM | MFCD00673203
7693-50-7
7693-50-7
2-Naphthyl chloroformate
AA003HON | MFCD00060059
833-50-1
833-50-1
2-Phenylbenzo[d]oxazole
AA003HSF | MFCD00012183
22408-41-9
22408-41-9
2-(Vinyloxy)tetrahydro-2H-pyran
AA003HVY | MFCD03093644
38747-02-3
38747-02-3
3-(3-Chloro-phenyl)-3-cyano-2-oxo-propionic acid ethyl ester
AA003HZH | MFCD16327924
93138-61-5
93138-61-5
[(1-Benzylpyrrolidin-3-yl)methyl]amine dihydrochloride
AA003I3A | MFCD09751752
373384-18-0
373384-18-0
3-Methylsulfonylphenylboronic acid
AA003I6C | MFCD03092935
3172-56-3
3172-56-3
3,3'-Bithiophene
AA003I9T | MFCD00041214
Submit
© 2017 AA BLOCKS, INC. All rights reserved.